SQZB (SQZ Biotechnologies Co) OCF Yield %: -10,484.34 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SQZB SQZ Biotechnologies Co SQZB
12 GF Score
Price $0.02
View Full Analysis

What is SQZ Biotechnologies Co OCF Yield %?

SQZ Biotechnologies Co SQZB 12 OCF Yield % is -10,484.34 as of Jul. 30, 2026. GuruFocus rates SQZB with a GF Score™ of 12/100.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, SQZ Biotechnologies Co's Trailing 12-Month Cash Flow from Operations is $-74.33 Mil, and Market Cap is $0.71 Mil. Therefore, SQZ Biotechnologies Co's OCF Yield % for today is -10,484.34%.

The historical rank and industry rank for SQZ Biotechnologies Co's OCF Yield % or its related term are showing as below:

SQZB' s OCF Yield % Range Over the Past 10 Years
Min: -10963.72   Med: 0   Max: -8399.32
Current: -10484.34


During the past 5 years, the highest OCF Yield % of SQZ Biotechnologies Co was -8399.32%. The lowest was -10963.72%. And the median was %.

SQZB's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.75 vs SQZB: -10484.34

SQZ Biotechnologies Co's OCF Margin % for the quarter that ended in Sep. 2023 was %.


SQZ Biotechnologies Co OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


SQZ Biotechnologies Co OCF Yield % Related Terms


SQZ Biotechnologies Co OCF Yield % Historical Data

* Premium members only.

The historical data trend for SQZ Biotechnologies Co's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SQZ Biotechnologies Co OCF Yield % Chart

SQZ Biotechnologies Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
OCF Yield %
0.00 0.00 -6.01 -32.69 -382.84

SQZ Biotechnologies Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -130.78 -380.51 -575.77 -767.09 -2,456.13

SQZB vs AGTX, ISCO, VYNT: OCF Yield % Comparison

For the Biotechnology subindustry, SQZ Biotechnologies Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SQZ Biotechnologies Co OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SQZ Biotechnologies Co's OCF Yield % distribution charts can be found below:

* The bar in red indicates where SQZ Biotechnologies Co's OCF Yield % falls into.


SQZB
12GF Score
SQZ Biotechnologies Co SQZB
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SQZ Biotechnologies Co OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

SQZ Biotechnologies Co's OCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-83.549 / 21.82334
=-382.84%

SQZ Biotechnologies Co's annualized OCF Yield % for the quarter that ended in Sep. 2023 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-14.532 * 4 / 2.36665275
=-2,456.13%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -10,484.34 mean?
SQZ Biotechnologies Co (SQZB) has a OCF Yield % of -10,484.34 as of Jul. 30, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SQZ Biotechnologies Co and its competitors.
Is SQZ Biotechnologies Co's OCF Yield % too high?
SQZ Biotechnologies Co's current OCF Yield % is -10,484.34. Overall, SQZ Biotechnologies Co has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does SQZ Biotechnologies Co's OCF Yield % compare to AGTX and ISCO?
SQZ Biotechnologies Co's OCF Yield % of -10,484.34 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on SQZ Biotechnologies Co and its competitors. SQZ Biotechnologies Co's current OCF Yield % is -10,484.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SQZ Biotechnologies Co stock overvalued right now?
SQZ Biotechnologies Co (SQZB) has a current OCF Yield % of -10,484.34. The current OCF Yield % is -10,484.34. SQZ Biotechnologies Co's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For SQZ Biotechnologies Co (SQZB), the current OCF Yield % is -10,484.34 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SQZ Biotechnologies Co Business Description

Address 200 Arsenal Yards Boulevard, Suite 210, Watertown, MA, USA, 02472
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ has the ability to deliver multiple materials into many patient cell types to engineer what it believes to be an unprecedented range of potential therapeutics for a range of diseases. The company has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and potentially improve the patient experience over existing cell therapy approaches, with accelerated production timelines under 24 hours and the elimination of preconditioning and lengthy hospital stays.
12GF Score

Get the complete analysis for SQZB

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price